Andrew Webb
Fortuna: 944 329 $ al 30/06/2026
Fortuna: 944 329 $ al 30/06/2026
Mr. Andrew J.
Webb is an Executive Chairman & Chief Executive Officer at CRISM Therapeutics Corp.
and a Chief Executive Officer & Director at Extruded Pharmaceuticals Ltd. He is on the Board of Directors at Novel Technologies Holdings Ltd. and Extruded Pharmaceuticals Ltd. Mr. Webb was previously employed as a Commercial Director by DxS Ltd., a Non-Executive Director by Arcis Biotechnology Ltd., and a Chief Executive Officer by EKF Molecular Diagnostics Ltd. He also served on the board at Convert2Green Ltd.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
9,22 % | 31/12/2025 | 7.297.190 ( 9,22 % ) | 944 329 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Miembro de la Junta | 23/11/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Corporate Officer/Principal | - |
EKF Molecular Diagnostics Ltd. | Director Ejecutivo | - |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Director/Miembro de la Junta | - |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 5 |
|---|---|
DxS Ltd.
DxS Ltd. Medical SpecialtiesHealth Technology Develops and manufactures molecular diagnostics products | Health Technology |
Convert2Green Ltd.
Convert2Green Ltd. Agricultural Commodities/MillingProcess Industries Provides renewable fuel solution | Process Industries |
Arcis Biotechnology Ltd.
Arcis Biotechnology Ltd. BiotechnologyHealth Technology Develops and researches surface protection technology | Health Technology |
EKF Molecular Diagnostics Ltd. | |
Novel Technologies Holdings Ltd.
Novel Technologies Holdings Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.